Funding: Sequana raises $26.2M for implantable bladder pump

Swiss medtech maker Sequana Medical closes a $26.2 million (CHF 23 million) Series C financing round in support of its alfapump implantable bladder pump for patients with liver disease.

Switzerland-based medtech company Sequana Medical has big plans for its newly-closed $26.2 million (CHF 23 million) Series C financing round, hoping to use the funds to widen its global sales and begin penetrating the U.S. market.

Sequana Medical AG

News Well, Funding Roundup, Implants

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/S2kVD8